powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1457731986
Katherine Podraza
MD PHD
Neurology
Mystic,
CT
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
PRESCRIBING · PART D · 2024
Total Rx claims
782
Beneficiaries
—
Total drug cost
$544K
Distinct drugs
23
Brand share
66.5%
Top prescribed drugs
Rimegepant Sulfate
109 claims
Ubrogepant
82 claims
Galcanezumab-Gnlm
82 claims
Atogepant
61 claims
Fremanezumab-Vfrm
51 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
68
Unique beneficiaries
—
Total services
5,925
Distinct HCPCS
4
Medicare payment
$43K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 263 Neurology providers in CT — top quintile (cohort median 349).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$662
Payment records
34
By payment type
Food and Beverage
$662
Top paying entities
Food and Beverage
$662
QUALITY · MIPS · 2024
Final MIPS score
90.4
Quality
83.4
Cost
75.9
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.65%
Group
